Abelcet and Aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abelcet (amphotericin b) and Aspirin (aspirin). Common drug interactions include bradycardia among females and red blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Abelcet and Aspirin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Abelcet?

Abelcet has active ingredients of amphotericin b. eHealthMe is studying from 853 Abelcet users. Check the latest studies of Abelcet.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,089 Aspirin users. Check the latest studies of Aspirin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

16 people who take Abelcet and Aspirin together, and have interactions are studied.

Abelcet and Aspirin drug interactions.

What are the common drug interactions of Abelcet and Aspirin, by gender? *:

female:

  1. Bradycardia (abnormally slow heart action)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Nodal rhythm (40-50 beats per minute)
  4. Pneumonia
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Chills (felling of cold)
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Death
  9. Dyspnoea (difficult or laboured respiration)
  10. Haematocrit

male:

  1. Red blood cell count decreased
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Cardiomegaly (increased size of heart than normal)
  4. Cerebral infarction (less blood supply to brain resulting tissue damage)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Confusional state
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Dyspnoea (difficult or laboured respiration)
  9. Fat embolism (fat obstruction due to injury)
  10. Fungaemia (fungi circulate in the blood)

What are the common drug interactions of Abelcet and Aspirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Haematocrit
  2. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)

20-29:

n/a

30-39:

n/a

40-49:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Agitation (state of anxiety or nervous excitement)
  3. Anaemia (lack of blood)
  4. Blood gases
  5. Cardiac arrest
  6. Cardiomegaly (increased size of heart than normal)
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Fat embolism (fat obstruction due to injury)
  10. Fungaemia (fungi circulate in the blood)

50-59:

  1. Blood creatinine increased

60+:

  1. Bradycardia (abnormally slow heart action)
  2. Nodal rhythm (40-50 beats per minute)
  3. Dyspnoea (difficult or laboured respiration)
  4. Infusion related reaction
  5. Kidney transplant rejection
  6. Oxygen saturation decreased
  7. Pallor
  8. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
  9. Pneumonia
  10. Pneumonia cryptococcal (pneumonia caused by cryptococcal infection)

What are the existing conditions these people have? *

  1. Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 3 people, 18.75%
  2. Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 6.25%
  4. Fungaemia (fungi circulate in the blood): 1 person, 6.25%
  5. Anaemia (lack of blood): 1 person, 6.25%
  6. Candida Sepsis (candida in blood stream): 1 person, 6.25%
  7. Constipation: 1 person, 6.25%
  8. Cryptococcosis (potentially fatal fungal disease): 1 person, 6.25%
  9. Cytomegalovirus Infection: 1 person, 6.25%
  10. Diabetes: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Abelcet and Aspirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abelcet and Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abelcet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abelcet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b and aspirin (the active ingredients of Abelcet and Aspirin, respectively), and Abelcet and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: